Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today announced a definitive agreement with the shareholders of Biotech Dental S.A.S., a rapidly growing provider of innovative clinical software and oral surgery and orthodontic products based in Salon-de-Provence, France, to acquire a majority ownership stake in the company. Henry Schein and Biotech Dental will partner to bring Biotech Dental’s full line of high-quality software, products, and services, including dental prostheses, clear aligners, dental implants, regenerative solutions, and biomaterials, to more dentists and dental laboratories as well as new geographies.
Read the full article: Henry Schein Makes Investment to Form Strategic Partnership with Biotech Dental Group //
Source: https://www.businesswire.com/news/home/20221215006058/en/Henry-Schein-Makes-Investment-to-Form-Strategic-Partnership-With-Biotech-Dental-Group